Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Breye Therapeutics ApS
APS
Active
Reklamebeskyttelse
CVR 40279865
Agern Alle 24, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 7 years old
4 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Breye Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
UM
Ulrik Mouritzen
Chief Executive Officer
Chief Executive Officer
2019
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (5)
JS
Jørgen Søberg Petersen
Board of Directors
Board of Directors
2022
GB
Gabriela Burian
Board of Directors
Board of Directors
2022
CR
Chiara Rossana Maria Liberati
Board of Directors
Board of Directors
2023
JA
Jimmy Arnold V Van Heusden
Chairman
Chairman
2022
CJ
Carl Johan Kördel
Board of Directors
Board of Directors
2022
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Novo Holdings A/S
Company
33.33–49.99%
33.33–49.99%
2024
Sound Bioventures Fund I AB
Individual
20–24.99%
20–24.99%
2023
Visus Holding ApS
Company
10–14.99%
10–14.99%
2024
BII Holdings A/S
Company
5–9.99%
5–9.99%
2023
Golgi NueroSciences S.R.L.
Individual
5–9.99%
5–9.99%
2024
Bradford A. Young
Individual
5–9.99%
5–9.99%
2020
BioInnovation Institute Fonden
Company
10–14.99%
10–14.99%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Breye Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
